Open Lending Corp

LPRO▼

Halper Sadeh LLC Investigates Whether LPRO, EQR, LEG, MDV Are Obtaining Fair Deals for Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating Open Lending Corporation, Equity Residential, Leggett & Platt, and Modiv Industrial for potential violations of federal securities laws or breaches of fiduciary duties in connection with their proposed transactions. The investigation concerns Open Lending's sale to ANV Group Holdings for $3.15 per share, Equity Residential's merger with AvalonBay Communities where Equity Residential shareholders would own about 48.8% of the combined company, Leggett & Platt's sale to Somnigroup International for 0.1455 shares of Somnigroup common stock per Leggett & Platt share resulting in Leggett & Platt shareholders owning approximately 9% of the combined company, and Modiv Industrial's sale to Global Net Lease where Modiv shareholders are expected to own roughly 11% of the combined company. The firm notes that insiders may receive substantial financial benefits not available to ordinary shareholders and that the proposed deals may contain terms limiting superior competing offers. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders.

EQR ▼LEG ▼LPRO ▼MDV ▼

EQR · Capital · Negative Investigation into merger with AvalonBay may indicate unfair terms for shareholders, potentially reducing deal value.

LEG · Capital · Negative Investigation into sale to Somnigroup may indicate unfair exchange ratio, harming shareholder value.

LPRO · Capital · Negative Investigation into sale to ANV Group at $3.15/share may indicate inadequate consideration.

MDV · Capital · Negative Investigation into sale to Global Net Lease may indicate unfair terms for Modiv shareholders.

Read original ↗

GlobeNewswire·96dRead more →

LPRO

Halper Sadeh LLC investigates Apogee, Open Lending, Huntsman, Avanos deals for shareholder fairness

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of Apogee Therapeutics, Open Lending Corporation, Huntsman Corporation, and Avanos Medical are obtaining fair deals for their shareholders. The firm is examining Apogee Therapeutics' sale to AbbVie for $135.11 per share in cash, Open Lending Corporation's sale to ANV Group Holdings Ltd. for $3.15 per share, Huntsman Corporation's sale to Olin Corporation for 0.5476 shares of Olin for each share of Huntsman, and Avanos Medical's sale to affiliates of American Industrial Partners for $25.00 per share in cash. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages affected investors to contact the firm to discuss their rights and options at no cost.

APGE AVNS HUN LPRO

APGE · Capital · Neutral Investigation into fairness of Apogee's sale to AbbVie may lead to increased consideration or deal changes.

AVNS · Capital · Neutral Investigation into fairness of Avanos Medical's sale to American Industrial Partners may lead to increased consideration or deal changes.

HUN · Capital · Neutral Investigation into fairness of Huntsman's sale to Olin Corporation may lead to increased consideration or deal changes.

LPRO · Capital · Neutral Investigation into fairness of Open Lending's sale to ANV Group Holdings may lead to increased consideration or deal changes.

Read original ↗

GlobeNewswire·102dRead more →

LPRO

Monteverde & Associates investigates mergers of Open Lending, Huntsman, Cross Country Healthcare, and Avanos Medical

Monteverde & Associates PC, a class action firm, is investigating the proposed mergers of four companies. Open Lending Corporation is being sold to ANV Group Holdings Ltd. for $3.15 per share in cash. Huntsman Corporation is being sold to Olin Corporation, with shareholders expected to receive 0.5476 shares of Olin for each Huntsman share. Cross Country Healthcare, Inc. is being sold to KL Criss Cross Intermediate, LLC for $13.25 per share in cash, with a shareholder vote scheduled for July 16, 2026. Avanos Medical, Inc. is being sold to affiliates of American Industrial Partners for $25.00 per share in cash, with a shareholder vote scheduled for July 22, 2026.

AVNS CCRN HUN LPRO OLN

AVNS · Capital · Neutral Avanos Medical is being acquired for $25.00 per share in cash; the investigation is standard procedure and does not indicate a problem with the deal.

CCRN · Capital · Neutral Cross Country Healthcare is being acquired for $13.25 per share in cash; the investigation is standard procedure and does not indicate a problem with the deal.

HUN · Capital · Neutral Huntsman Corporation is being acquired by Olin Corporation in a stock-for-stock merger; the investigation is standard procedure and does not indicate a problem with the deal.

LPRO · Capital · Neutral Open Lending Corporation is being acquired for $3.15 per share in cash; the investigation is standard procedure and does not indicate a problem with the deal.

American Industrial Partners · Capital · Positive American Industrial Partners is acquiring Avanos Medical for $25.00 per share in cash, a positive deal for the buyer if the acquisition is accretive.

ANV Group Holdings Ltd. · Capital · Positive ANV Group Holdings Ltd. is acquiring Open Lending Corporation for $3.15 per share in cash, a positive deal for the buyer if the acquisition is accretive.

Read original ↗

GlobeNewswire·103dRead more →

LPRO

Brodsky & Smith investigates boards of AstroNova, Open Lending, Huntsman, and Standard BioTools over merger deals

Brodsky & Smith is investigating potential fiduciary duty breaches by the boards of four companies in connection with their announced mergers. AstroNova is being acquired by Arcline Investment Management for $29.00 per share in an all-cash deal valued at approximately $272 million. Open Lending is being acquired by ANV Group Holdings for $3.15 per share. Huntsman is being acquired by Olin Corporation, with Huntsman shareholders receiving 0.5476 Olin shares for each Huntsman share, resulting in Huntsman shareholders owning about 45.5% of the combined company. Standard BioTools is being acquired by Treeline Biosciences, with pre-merger Standard BioTools stockholders expected to own approximately 16% of the combined company. The investigations focus on whether the boards failed to conduct a fair process and whether the deal consideration provides fair value to shareholders.

ALOT HUN LAB LPRO OLN

ALOT · Capital · Neutral Investigation into board's fiduciary duties regarding $29/share acquisition deal; outcome uncertain.

HUN · Capital · Neutral Investigation into board's fiduciary duties regarding Olin merger; deal consideration may be unfair.

LAB · Capital · Neutral Investigation into board's fiduciary duties regarding Treeline Biosciences merger; shareholders get 16% of combined company.

LPRO · Capital · Neutral Investigation into board's fiduciary duties regarding ANV Group Holdings acquisition at $3.15/share.

OLN · Capital · Neutral Olin is the acquirer in Huntsman merger; investigation may affect deal terms or reputation.

Read original ↗

GlobeNewswire·107dRead more →

LPRO

Halper Sadeh LLC Investigates Fairness of Deals for LPRO, NUVL, OGN, SUNE Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed sales of Open Lending Corporation, Nuvalent Inc., Organon & Co., and SUNation Energy Inc. are fair to shareholders. The firm is examining Open Lending's sale to ANV Group Holdings Ltd. for $3.15 per share, Nuvalent's sale to GSK plc for $124.00 per share in cash, Organon's sale to Sun Pharmaceutical Industries Limited for $14.00 per share, and SUNation Energy's merger with Suniva, in which SUNation shareholders would own approximately 1.8% of the combined company. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages investors to contact the firm to discuss their rights at no cost.

LPRO NUVL OGN SUNE

LPRO · Capital · Neutral Investigation into fairness of Open Lending's sale to ANV Group Holdings for $3.15 per share; may seek increased consideration or additional disclosures.

NUVL · Capital · Neutral Investigation into fairness of Nuvalent's sale to GSK for $124.00 per share; may seek increased consideration or additional disclosures.

OGN · Capital · Neutral Investigation into fairness of Organon's sale to Sun Pharmaceutical for $14.00 per share; may seek increased consideration or additional disclosures.

SUNE · Capital · Neutral Investigation into fairness of SUNation Energy's merger with Suniva, where SUNation shareholders would own ~1.8% of combined company; may seek increased consideration or additional disclosures.

Read original ↗

GlobeNewswire·109dRead more →